Tissue iron evaluation in chronically transfused children shows significant levels of iron loading at a very young age

American Journal of Hematology

Volumn 88, Issue 11, 2013, Pages

  Berdoukas, Vasilios ^a   Nord, Anne ^a   Carson, Susan ^a   Puliyel, Mammen ^a   Hofstra, Thomas ^a   Wood, John ^b   Coates, Thomas D ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

ARTICLE; BLACKFAN DIAMOND ANEMIA; BLOOD TRANSFUSION; BONE MARROW SUPPRESSION; CARDIOMYOPATHY; CHILD; CONGENITAL DYSERYTHROPOIETIC ANEMIA; DRY WEIGHT; GROUPS BY AGE; HEART; HIGH RISK POPULATION; HUMAN; IRON OVERLOAD; LIVER; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; THALASSEMIA MAJOR;

ANEMIA; ANEMIA, DIAMOND-BLACKFAN; ANEMIA, DYSERYTHROPOIETIC, CONGENITAL; BETA-THALASSEMIA; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; ERYTHROPOIESIS; HOSPITALS, PEDIATRIC; HUMANS; IRON; IRON OVERLOAD; LIVER; LOS ANGELES; MAGNETIC RESONANCE IMAGING; MYOCARDIUM; PANCREAS; RETROSPECTIVE STUDIES; RISK;

EID: 84886264328     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23543     Document Type: Article

References (14)

1. Wood JC, Tyszka JM, Carson S, et al. Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. Blood 2004;103:1934-1936.
2. Wood JC, Enriquez C, Ghugre N, et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 2005;106:1460-1465.
3. St Pierre TG, Clark PR, Chua-Anusorn W, et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 2005;105:855-861.
4. Noetzli LJ, Mittelman SD, Watanabe RM, et al. Pancreatic iron and glucose dysregulation in thalassemia major. Am J Hematol 2012;87:155-160.
5. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22:2171-2179.
6. Noetzli LJ, Panigrahy A, Hyderi A, et al. Pituitary iron and volume imaging in healthy controls. AJNR Am J Neuroradiol 2012;33:259-265.
7. Noetzli LJ, Mittelman SD, Watanabe RM, et al. Pancreatic iron and glucose dysregulation in thalassemia major. Am J Hematol 2012;87:155-160.
8. Kirk P, Roughton M, Porter JB, et al. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation 2009;120:1961-1968.
9. Wood JC, Glynos T, Thompson A, et al. Relationship between labile plasma iron, liver iron concentration and cardiac response in a deferasirox monotherapy trial. Haematologica 2011;96:1055-1058.
10. Noetzli LJ, Papudesi J, Coates TD, et al. Pancreatic iron loading predicts cardiac iron loading in thalassemia major. Blood 2009;114:4021-4026.
11. Ruccione KS, Mudambi K, Sposto R, et al. Association of projected transfusional iron burden with treatment intensity in childhood cancer survivors. Pediatr Blood Cancer 2012;59:697-702.
12. Sahlstedt L, von Bonsdorff L, Ebeling F, et al. Non-transferrin-bound iron in haematological patients during chemotherapy and conditioning for autologous stem cell transplantation. Eur J Haematol 2009;83:455-459.
13. Berdoukas V, Farmaki K, Wood JC, et al. Iron chelation in thalassemia: time to reconsider our comfort zones. Expert Rev Hematol 2011;4:17-26.
14. Noetzli LJ, Panigrahy A, Mittelman SD, et al. Pituitary iron and volume predict hypogonadism in transfusional iron overload. Am J Hematol 2012;87:167-171.